Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Trey Ideker
University of California, San Diego, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
Ideaya Biosciences
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Ideker is on the Scientific Advisory Board for Ideaya Biosciences (Ideaya), holds (b)(4) equity valued between (b)(4) and receives income in the range of (b)(4). Ideaya is an oncology focused company committed to the discovery of breakthrough synthetic lethality medicines targeting DNA damage and repair for genetically defined patient populations and for enhancing immunotherapy response, and immune-oncology therapies targeting the tumor micro-environment. This project will use systematic approaches to map and model the genetic networks underlying the DNA damage response. These maps are a major biomedical resource which will be used to identify and target chemotherapeutic agents and their modulators.
A Systems Approach to Mapping the DNA Damage Response
We propose to develop comprehensive maps and models of signal transduction networks in response to DNA damage. These maps are a major biomedical resource which will be used to identify and target chemotherapeutic agents and their modulators.
Filed on November 20, 2017.
Tell us what you know about Trey Ideker's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Trey Ideker filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Trey Ideker | University of California, San Diego | Conflict of Interest | Ideaya Biosciences | $10,000 - $19,999 |
Other search results for: “Trey Ideker”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Trey Ideker | University of California, San Diego | Financial Disclosure | Ideaya Biosciences, Inc. |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.